Comparison of the effects of the CCK-receptor antagonist loxiglumide and the M1-receptor antagonist telenzepine on the pancreatic protein response to intraduodenal tryptophan in dogs. First results.
Teyssen
S
S
Department of Medicine IV (Gastroenterology), University Hospital of Heidelberg at Mannheim, Germany.
Singer
M V
MV
D000818:Animals; D004285:Dogs; D004386:Duodenum / Q000187:drug effects / Q000502:physiology*; D005260:Female; D008297:Male; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D010189:Pancreatic Juice / Q000378:metabolism*; D010276:Parasympatholytics / Q000494:pharmacology*; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011377:Proglumide / Q000031:analogs & derivatives* / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors*; D012633:Secretin / Q000494:pharmacology; D014364:Tryptophan / Q000494:pharmacology*
D010276:Parasympatholytics; D011506:Proteins; D011949:Receptors, Cholecystokinin; C046338:telenzepine; D012633:Secretin; D010890:Pirenzepine; C053737:loxiglumide; D014364:Tryptophan; D011377:Proglumide